Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01987999
PHASE2
A Nutraceutical Intervention in Patients With Previously Untreated Human Prostate Cancer
Sponsor: Optimal Health Research
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate weather a novel nutraceutical intervention (F-989) can improve prostate-specific antigerm (PSA) levels and Gleason scores in prostate cancer patients who are on active surveillance.
Official title: Evaluation of a Novel Nutraceutical Intervention (F-989) in Prostate Cancer Patients on Active Surveillance
Key Details
Gender
MALE
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2013-02
Completion Date
2015-12
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
Acetogenins
A novel, complex nutraceutical (F-989) that includes herbs, enzymes, phytonutrients, vitamins, and minerals.